Published in Am J Cardiol on January 15, 2004
Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 3.48
Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther (2009) 3.47
Systemic lupus erythematosus and the risk of cardiovascular disease: results from the nurses' health study. Arthritis Rheum (2009) 2.26
Cardiovascular morbidity and mortality in rheumatoid arthritis. Am J Med (2008) 1.77
Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus. Am J Med (2008) 1.70
Why do people with rheumatoid arthritis still die prematurely? Ann Rheum Dis (2008) 1.28
Incidence of and risk factors for adverse cardiovascular events among patients with systemic lupus erythematosus. Am J Epidemiol (2012) 1.27
Validity of myocardial infarction diagnoses in administrative databases: a systematic review. PLoS One (2014) 1.20
The inextricable link between atherosclerosis and prototypical inflammatory diseases rheumatoid arthritis and systemic lupus erythematosus. Arthritis Res Ther (2009) 1.15
No increased risk of myocardial infarction among patients with ulcerative colitis or Crohn's disease. Clin Gastroenterol Hepatol (2011) 1.05
Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions. Eur Heart J (2014) 1.04
Cardiorheumatology: cardiac involvement in systemic rheumatic disease. Nat Rev Cardiol (2014) 0.91
Lack of cardiovascular risk assessment in inflammatory arthritis and systemic lupus erythematosus patients at a tertiary care center. Clin Rheumatol (2011) 0.90
Early vascular alterations in SLE and RA patients--a step towards understanding the associated cardiovascular risk. PLoS One (2012) 0.88
Activation of type I interferon pathway in systemic lupus erythematosus: association with distinct clinical phenotypes. J Biomed Biotechnol (2011) 0.86
Association of paraoxonase 1 gene polymorphism and enzyme activity with carotid plaque in rheumatoid arthritis. Arthritis Rheum (2013) 0.85
Management of cardiovascular complications in systemic lupus erythematosus. Int J Clin Rheumtol (2010) 0.85
Long-term anti-tumour necrosis factor therapy reverses the progression of carotid intima-media thickness in female patients with active rheumatoid arthritis. Rheumatol Int (2009) 0.84
Cardiovascular involvement in autoimmune diseases. Biomed Res Int (2014) 0.82
Cardiovascular risk and acute coronary syndrome in giant cell arteritis: a population-based retrospective cohort study. Arthritis Care Res (Hoboken) (2015) 0.82
Prevalence of LDL atherogenic phenotype in patients with systemic lupus erythematosus. Vasc Health Risk Manag (2011) 0.81
Cardiovascular disease and rheumatoid arthritis: an update. Curr Rheumatol Rep (2012) 0.81
A Large-Scale Study Indicates Increase in the Risk of Epilepsy in Patients With Different Risk Factors, Including Rheumatoid Arthritis. Medicine (Baltimore) (2015) 0.80
Increased prevalence of subclinical atherosclerosis in rheumatoid arthritis patients of Indian descent. Exp Clin Cardiol (2012) 0.80
Cardiovascular disease in latin american patients with systemic lupus erythematosus: a cross-sectional study and a systematic review. Autoimmune Dis (2013) 0.80
Risk of Peripheral Arterial Occlusive Disease in Patients With Systemic Lupus Erythematosus: A Nationwide Population-Based Cohort Study. Medicine (Baltimore) (2015) 0.80
Impact of parental history on patients' cardiovascular mortality in rheumatoid arthritis. Ann Rheum Dis (2005) 0.80
Von Willebrand factor, red cell fragmentation, and disease activity in systemic lupus erythematosus. HSS J (2008) 0.78
The endothelial tyrosine phosphatase SHP-1 plays an important role for vascular haemostasis in TNFα -induced inflammation in vivo. Mediators Inflamm (2013) 0.78
Association of systemic lupus erythematosus with angiographically defined coronary artery disease: a retrospective cohort study. Arthritis Care Res (Hoboken) (2013) 0.78
Effect of the Diagnosis of Inflammatory Bowel Disease on Risk-Adjusted Mortality in Hospitalized Patients with Acute Myocardial Infarction, Congestive Heart Failure and Pneumonia. PLoS One (2016) 0.77
High-risk periodontal pathogens contribute to the pathogenesis of atherosclerosis. Postgrad Med J (2016) 0.77
Nephritis and the risk of acute myocardial infarction in patients with systemic lupus erythematosus. Clin Exp Rheumatol (2010) 0.77
Prevalence of dyslipidemia in Japanese patients with rheumatoid arthritis and effects of atorvastatin treatment. Clin Rheumatol (2015) 0.77
Disease-modifying antirheumatic drug use and the risk of incident hyperlipidemia in patients with early rheumatoid arthritis: a retrospective cohort study. Arthritis Care Res (Hoboken) (2015) 0.76
High iron stores and ischemic heart disease in rheumatoid arthritis and systemic lupus erythematosus. Am J Cardiol (2004) 0.75
Cardiovascular Disease Outcomes Associated with Three Major Inflammatory Dermatologic Diseases: A Propensity-Matched Case Control Study. Dermatol Ther (Heidelb) (2016) 0.75
First time myocardial infarction in a rheumatic patient after elective arthroplasty. HSS J (2013) 0.75
Multifactorial intervention to prevent cardiovascular disease in patients with early rheumatoid arthritis: protocol for a multicentre randomised controlled trial. BMJ Open (2016) 0.75
Cardiovascular disease in immune-mediated inflammatory diseases: A cross-sectional analysis of 6 cohorts. Medicine (Baltimore) (2017) 0.75
[Therapy of dyslipidemia in rheumatic diseases]. Z Rheumatol (2010) 0.75
Arterial stiffness and peripheral arterial disease in patients with systemic lupus erythematosus. Rheumatol Int (2016) 0.75
Validity of the general practice research database. Pharmacotherapy (2003) 6.78
Long-term metformin use is associated with decreased risk of breast cancer. Diabetes Care (2010) 3.68
Recombinant hepatitis B vaccine and the risk of multiple sclerosis: a prospective study. Neurology (2004) 3.21
Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol. Contraception (2006) 3.01
Use of thiazolidinediones and fracture risk. Arch Intern Med (2008) 2.99
Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group. Ann Allergy Asthma Immunol (2006) 2.85
Use of antihypertensives and the risk of Parkinson disease. Neurology (2008) 2.51
Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia: a nested case-control analysis. Diabetes Care (2008) 2.33
Statin use and risk of gallstone disease followed by cholecystectomy. JAMA (2009) 2.31
Testosterone lab testing and initiation in the United Kingdom and the United States, 2000 to 2011. J Clin Endocrinol Metab (2014) 2.18
Hepatotoxicity during rapid intravenous loading with amiodarone: Description of three cases and review of the literature. Crit Care Med (2005) 1.77
Relation of childhood gastrointestinal disorders to autism: nested case-control study using data from the UK General Practice Research Database. BMJ (2002) 1.69
Proton pump inhibitor use and risk of hip fractures in patients without major risk factors. Pharmacotherapy (2008) 1.67
Postmenopausal estrogen-containing hormone therapy and the risk of breast cancer. Obstet Gynecol (2009) 1.66
Statins and the risk of idiopathic venous thromboembolism. Br J Clin Pharmacol (2002) 1.65
Psoriasis and risk of incident cancer: an inception cohort study with a nested case-control analysis. J Invest Dermatol (2009) 1.62
Statins and the risk of pneumonia: a population-based, nested case-control study. Pharmacotherapy (2007) 1.61
Use of beta-blockers and risk of fractures. JAMA (2004) 1.58
Further results on the risk of nonfatal venous thromboembolism in users of the contraceptive transdermal patch compared to users of oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol. Contraception (2007) 1.57
Time trends in eating disorder incidence. Br J Psychiatry (2005) 1.53
Cigarette smoking and the progression of multiple sclerosis. Brain (2005) 1.52
Association between acetaminophen or nonsteroidal antiinflammatory drugs and risk of developing ovarian, breast, or colon cancer. Pharmacotherapy (2002) 1.46
Antibiotic use and risk of multiple sclerosis. Am J Epidemiol (2006) 1.45
Lymphoma among patients with atopic dermatitis and/or treated with topical immunosuppressants in the United Kingdom. J Allergy Clin Immunol (2009) 1.45
Use of metformin is not associated with a decreased risk of colorectal cancer: a case-control analysis. Cancer Epidemiol Biomarkers Prev (2011) 1.44
Cesarean delivery in the United Kingdom: time trends in the general practice research database. Obstet Gynecol (2005) 1.44
Diabetes mellitus and the risk of cholecystectomy. Dig Liver Dis (2011) 1.44
Potential drug-drug interactions in the medication of medical patients at hospital discharge. Eur J Clin Pharmacol (2003) 1.42
Incidence of the pneumoconioses in the United Kingdom general population between 1997 and 2008. Respiration (2012) 1.41
Chronic obstructive pulmonary disease and the risk of cardiovascular diseases. Eur J Epidemiol (2010) 1.41
Statin use and risk of first-time psoriasis diagnosis. J Am Acad Dermatol (2011) 1.41
Using prescription claims data for drugs available over-the-counter (OTC). Pharmacoepidemiol Drug Saf (2007) 1.39
A population-based study of the incidence, cause, and severity of anaphylaxis in the United Kingdom. Arch Intern Med (2004) 1.38
Use of metformin and the risk of ovarian cancer: a case-control analysis. Gynecol Oncol (2011) 1.38
Acute pancreatitis in association with type 2 diabetes and antidiabetic drugs: a population-based cohort study. Diabetes Care (2010) 1.32
Use of nonsteroidal anti-inflammatory drugs and the risk of first-time acute myocardial infarction. Br J Clin Pharmacol (2002) 1.30
Recent use of oral contraceptives and the risk of multiple sclerosis. Arch Neurol (2005) 1.27
Use of antidiabetic agents and the risk of pancreatic cancer: a case-control analysis. Am J Gastroenterol (2012) 1.27
Current use of selective serotonin reuptake inhibitors and risk of acute myocardial infarction. Drug Saf (2004) 1.25
COPD and the risk of depression. Chest (2009) 1.23
Drug interactions and risk of acute bleeding leading to hospitalisation or death in patients with chronic atrial fibrillation treated with warfarin. Thromb Haemost (2005) 1.23
Metformin, other antidiabetic drugs, and risk of Alzheimer's disease: a population-based case-control study. J Am Geriatr Soc (2012) 1.22
Risk of cholestatic liver disease associated with flucloxacillin and flucloxacillin prescribing habits in the UK: cohort study using data from the UK General Practice Research Database. Br J Clin Pharmacol (2005) 1.17
Metformin does not alter the risk of lung cancer: a case-control analysis. Lung Cancer (2012) 1.17
Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel. Contraception (2006) 1.15
Benzodiazepine prescribing to the Swiss adult population: results from a national survey of community pharmacies. Int Clin Psychopharmacol (2007) 1.14
Changes in antipsychotic drug prescribing by general practitioners in the United Kingdom from 1991 to 2000: a population-based observational study. Br J Clin Pharmacol (2003) 1.13
The FDA extended warning for intravenous haloperidol and torsades de pointes: how should institutions respond? J Hosp Med (2010) 1.10
MMR vaccine and idiopathic thrombocytopaenic purpura. Br J Clin Pharmacol (2003) 1.10
Systematic review of medication safety assessment methods. Am J Health Syst Pharm (2011) 1.08
Rhabdomyolysis in association with simvastatin and amiodarone. Ann Pharmacother (2004) 1.06
The prevalence of potential drug-drug interactions in patients with heart failure at hospital discharge. Drug Saf (2006) 1.04
Incident diabetes associated with antipsychotic use in the United Kingdom general practice research database. J Clin Psychiatry (2002) 1.04
Prevalence of potentially inappropriate medication use in elderly patients: comparison between general medical and geriatric wards. Drugs Aging (2006) 1.03
Risk for incident atrial fibrillation in patients who receive antihypertensive drugs: a nested case-control study. Ann Intern Med (2010) 1.03
Trends in incidence and medical resource utilisation in patients with chronic lymphocytic leukaemia: insights from the UK Clinical Practice Research Datalink (CPRD). Ann Hematol (2014) 1.02
Use of statins and the risk of Parkinson's disease: a retrospective case-control study in the UK. Drug Saf (2008) 1.02
Diabetes in patients with idiopathic Parkinson's disease. Diabetes Care (2008) 1.01
Appropriateness of serum level determinations of antiepileptic drugs. Swiss Med Wkly (2003) 1.01
Age-related differences in the prevalence of potential drug-drug interactions in ambulatory dyslipidaemic patients treated with statins. Drugs Aging (2007) 1.00
Discontinuation of nonsteroidal anti-inflammatory drug therapy and risk of acute myocardial infarction. Arch Intern Med (2004) 1.00
Etiology and frequency of rhabdomyolysis. Pharmacotherapy (2002) 1.00
Migraine and the risk of stroke, TIA, or death in the UK (CME). Headache (2007) 0.99
Current use of nonsteroidal antiinflammatory drugs and the risk of acute myocardial infarction. Pharmacotherapy (2005) 0.99
Topical treatments with pimecrolimus, tacrolimus and medium- to high-potency corticosteroids, and risk of lymphoma. Dermatology (2009) 0.98
Prevalence of potentially severe drug-drug interactions in ambulatory patients with dyslipidaemia receiving HMG-CoA reductase inhibitor therapy. Drug Saf (2005) 0.98
Association between use of thiazolidinediones or other oral antidiabetics and psoriasis: A population based case-control study. J Am Acad Dermatol (2008) 0.97
Epidemiology, co-morbidities, and medication use of patients with Alzheimer's disease or vascular dementia in the UK. J Alzheimers Dis (2013) 0.96
Cancer risk in association with Parkinson disease: a population-based study. Parkinsonism Relat Disord (2009) 0.95
In vitro fertilization and childhood retinoblastoma. Br J Clin Pharmacol (2004) 0.94
Lipid-lowering drugs and the risk of depression and suicidal behavior. Arch Intern Med (2003) 0.93
Prevalence and incidence rates of autism in the UK: time trend from 2004-2010 in children aged 8 years. BMJ Open (2013) 0.92
Seizures in patients with Alzheimer's disease or vascular dementia: a population-based nested case-control analysis. Epilepsia (2012) 0.91
Effect of selective serotonin reuptake inhibitors on platelet activation: can they prevent acute myocardial infarction? Am J Cardiovasc Drugs (2003) 0.91
Risk of stroke in patients with idiopathic Parkinson disease. Parkinsonism Relat Disord (2009) 0.90
Use of diuretics and risk of incident gout: a population-based case-control study. Arthritis Rheumatol (2014) 0.90
Incidence of autism over time. Epidemiology (2006) 0.89
Appropriateness of digoxin level monitoring. Swiss Med Wkly (2002) 0.89
Comment on: Suissa and Azoulay. Metformin and the risk of cancer: time-related biases in observational studies. Diabetes Care 2012;35:2665-2673. Diabetes Care (2013) 0.88
The contraceptive patch in relation to ischemic stroke and acute myocardial infarction. Pharmacotherapy (2007) 0.88
Risk of fractures with glitazones: a critical review of the evidence to date. Drug Saf (2009) 0.87
Association between body mass index and liver disorders: an epidemiological study. J Hepatol (2002) 0.86
Reflux disease, gastrointestinal ulcer or weight loss in patients with COPD. COPD (2010) 0.86
Comparative safety of antipsychotics in the WHO pharmacovigilance database: the haloperidol case. Int J Clin Pharm (2011) 0.85
Case-control analysis on metformin and cancer of the esophagus. Cancer Causes Control (2013) 0.85
Inhaled corticosteroids and the risk of fractures in children and adolescents. Pediatrics (2004) 0.84